Integrative Bioinformatics Analysis of Herbal Compound–Target Interactions in Precision Medicine

Abstract

The shift toward precision medicine has created both opportunities and challenges for integrating herbal pharmacopeias into modern therapeutic reasoning. Herbal medicines are intrinsically multi-component and multi-target, which makes them poorly suited to reductionist single-target discovery models. Integrative bioinformatics now offers a systems-level pathway for analyzing compound-target interactions across heterogeneous molecular, pharmacological, and clinical data. This paper examines the conceptual foundations, architectural strategies, network-based inference methods, and clinical translation pathways that connect herbal compound interaction data to precision medicine. It argues that the value of integrative analysis lies not merely in predicting isolated interactions, but in structurally encoding uncertainty, polypharmacology, synergy, and patient variability within interpretable systems. The discussion addresses data integration architectures, network medicine representations, machine learning deployment, governance, fairness, reproducibility, and policy implications. Rather than treating herbal network pharmacology as a supplement to conventional drug discovery, the paper positions it as a distinct socio-technical infrastructure requiring careful management of provenance, semantic heterogeneity, and clinical accountability. Structural trade-offs between model expressiveness, interpretability, and scalability are analyzed through cross-domain comparisons with genomic and pharmacovigilance systems. The conclusion emphasizes that sustainable precision medicine will require governance models that protect against algorithmic bias while preserving the therapeutic pluralism represented by herbal medicines.